<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1221"/><api:result><api:object category="publication" id="1221" last-affected-when="2024-03-16T19:34:26.12+00:00" last-modified-when="2024-03-16T19:34:26.12+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1221" created-when="2010-05-17T13:47:33.823+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-25</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518218" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2796.2000.00714.x" last-modified-when="2023-11-04T10:27:48.697+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;&lt;jats:bold&gt;Abstract.&lt;/jats:bold&gt; Moerman CJ, van Hout BA, Bonneux L, Witteman JCM (University of Amsterdam, Amsterdam, and Erasmus University Medical School, Rotterdam, the Netherlands). Postmenopausal hormone therapy: less favourable risk–benefit ratios in healthy Dutch women. &lt;jats:italic&gt;J Intern Med&lt;/jats:italic&gt; 2000; &lt;jats:bold&gt;248:&lt;/jats:bold&gt; 143–150.&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:bold&gt;Objectives.&lt;/jats:bold&gt; To estimate the health effects of postmenopausal hormone therapy used for 10 or 20 years in a population of intermediate cardiovascular risk.&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:bold&gt;Design.&lt;/jats:bold&gt; Using existing estimates of the effect of hormone therapy on rates of myocardial infarction, hip fracture and breast cancer, a proportional multistage life table was generated to calculate the effects of use for 10 and 20 years in a synthetic cohort of Dutch women aged 55 with an average and a high‐risk profile for cardiovascular disease.&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:bold&gt;Results.&lt;/jats:bold&gt; A woman of the general population who starts hormone therapy at age 55 for 10 years can prolong her life by 1 month and may postpone the occurrence of first incidence of one of the diseases under consideration by 2.4 months. One excess breast cancer case is likely to occur per 5–6 averted cases of first myocardial infarction or hip fracture. If she prolongs her use to 20 years, the gain of life expectancy and disease‐free life expectancy is doubled. The risk–benefit ratio worsens to one extra breast cancer per 3–4 averted cases of the preventable diseases. For a woman with a high‐risk profile, the gains in health are about twice as high as for her counterpart in the general population, and her risk–benefit ratio is also more favourable. Yet, the risk–benefit ratio still worsens for 20 as compared with 10 years of use.&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:bold&gt;Conclusions.&lt;/jats:bold&gt; Women from the general population in the Netherlands and similar populations can achieve only a modest gain in life expectancy by using hormones during 10 or 20 years following menopause. This is a consequence of the low incidence of myocardial infarction and hip fracture and the relatively high incidence of breast cancer before the age of 75. Women at increased cardiovascular risk can benefit more from hormone therapy. But even amongst these women, the risk of breast cancer incurred with long‐term use offsets much of the benefit that could accrue from changing the risk of heart disease and hip fracture.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JCM</api:initials><api:first-names>JCM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2796</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Internal Medicine</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2796.2000.00714.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk–benefit ratios in healthy Dutch women</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="131479" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033853622" last-modified-when="2021-12-07T22:57:08.197+00:00"><api:citation-count>7</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Objectives. To estimate the health effects of postmenopausal hormone therapy used for 10 or 20 years in a population of intermediate cardiovascular risk. Design. Using existing estimates of the effect of hormone therapy on rates of myocardial infarction, hip fracture and breast cancer, a proportional multistage life table was generated to calculate the effects of use for 10 and 20 years in a synthetic cohort of Dutch women aged 55 with an average and a high-risk profile for cardiovascular disease. Results. A woman of the general population who starts hormone therapy at age 55 for 10 years can prolong her life by 1 month and may postpone the occurrence of first incidence of one of the diseases under consideration by 2.4 months. One excess breast cancer case is likely to occur per 5-6 averted cases of first myocardial infarction or hip fracture. If she prolongs her use to 20 years, the gain of life expectancy and disease-free life expectancy is doubled. The risk-benefit ratio worsens to one extra breast cancer per 3-4 averted cases of the preventable diseases. For a woman with a high-risk profile, the gains in health are about twice as high as for her counterpart in the general population, and her risk-benefit ratio is also more favourable. Yet, the risk-benefit ratio still worsens for 20 as compared with 10 years of use. Conclusions. Women from the general population in the Netherlands and similar populations can achieve only a modest gain in life expectancy by using hormones during 10 or 20 years following menopause. This is a consequence of the low incidence of myocardial infarction and hip fracture and the relatively high incidence of breast cancer before the age of 75. Women at increased cardiovascular risk can benefit more from hormone therapy. But even amongst these women, the risk of breast cancer incurred with long-term use offsets much of the benefit that could accrue from changing the risk of heart disease and hip fracture.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Universiteit van Amsterdam</api:line><api:line type="city">Amsterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003489877</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus Universiteit Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57191081993</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus MC</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005877904</api:identifier></api:identifiers></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JCM</api:initials><api:first-names>JCM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus MC</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005473334</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947893</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Internal Medicine</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: Less favourable risk-benefit ratios in healthy Dutch women</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="1221" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10947893" last-modified-when="2020-04-29T06:12:34.94+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>OBJECTIVES: To estimate the health effects of postmenopausal hormone therapy used for 10 or 20 years in a population of intermediate cardiovascular risk. DESIGN: Using existing estimates of the effect of hormone therapy on rates of myocardial infarction, hip fracture and breast cancer, a proportional multistage life table was generated to calculate the effects of use for 10 and 20 years in a synthetic cohort of Dutch women aged 55 with an average and a high-risk profile for cardiovascular disease. RESULTS: A woman of the general population who starts hormone therapy at age 55 for 10 years can prolong her life by 1 month and may postpone the occurrence of first incidence of one of the diseases under consideration by 2.4 months. One excess breast cancer case is likely to occur per 5-6 averted cases of first myocardial infarction or hip fracture. If she prolongs her use to 20 years, the gain of life expectancy and disease-free life expectancy is doubled. The risk-benefit ratio worsens to one extra breast cancer per 3-4 averted cases of the preventable diseases. For a woman with a high-risk profile, the gains in health are about twice as high as for her counterpart in the general population, and her risk-benefit ratio is also more favourable. Yet, the risk-benefit ratio still worsens for 20 as compared with 10 years of use. CONCLUSIONS: Women from the general population in the Netherlands and similar populations can achieve only a modest gain in life expectancy by using hormones during 10 or 20 years following menopause. This is a consequence of the low incidence of myocardial infarction and hip fracture and the relatively high incidence of breast cancer before the age of 75. Women at increased cardiovascular risk can benefit more from hormone therapy. But even amongst these women, the risk of breast cancer incurred with long-term use offsets much of the benefit that could accrue from changing the risk of heart disease and hip fracture.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="full">Department of Gender and Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JC</api:initials><api:first-names>JC</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10947893</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Intern Med</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Breast Neoplasms</api:keyword><api:keyword scheme="mesh">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Hip Fractures</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>jim714</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>21</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="882310" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10947893" last-modified-when="2021-01-19T17:57:50.28+00:00"><api:citation-count>4</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Objectives&lt;/h4&gt;To estimate the health effects of postmenopausal hormone therapy used for 10 or 20 years in a population of intermediate cardiovascular risk.&lt;h4&gt;Design&lt;/h4&gt;Using existing estimates of the effect of hormone therapy on rates of myocardial infarction, hip fracture and breast cancer, a proportional multistage life table was generated to calculate the effects of use for 10 and 20 years in a synthetic cohort of Dutch women aged 55 with an average and a high-risk profile for cardiovascular disease.&lt;h4&gt;Results&lt;/h4&gt;A woman of the general population who starts hormone therapy at age 55 for 10 years can prolong her life by 1 month and may postpone the occurrence of first incidence of one of the diseases under consideration by 2.4 months. One excess breast cancer case is likely to occur per 5-6 averted cases of first myocardial infarction or hip fracture. If she prolongs her use to 20 years, the gain of life expectancy and disease-free life expectancy is doubled. The risk-benefit ratio worsens to one extra breast cancer per 3-4 averted cases of the preventable diseases. For a woman with a high-risk profile, the gains in health are about twice as high as for her counterpart in the general population, and her risk-benefit ratio is also more favourable. Yet, the risk-benefit ratio still worsens for 20 as compared with 10 years of use.&lt;h4&gt;Conclusions&lt;/h4&gt;Women from the general population in the Netherlands and similar populations can achieve only a modest gain in life expectancy by using hormones during 10 or 20 years following menopause. This is a consequence of the low incidence of myocardial infarction and hip fracture and the relatively high incidence of breast cancer before the age of 75. Women at increased cardiovascular risk can benefit more from hormone therapy. But even amongst these women, the risk of breast cancer incurred with long-term use offsets much of the benefit that could accrue from changing the risk of heart disease and hip fracture.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="NL"><api:line type="full">Department of Gender and Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JC</api:initials><api:first-names>JC</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2796</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947893</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of internal medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Breast Neoplasms</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Hip Fractures</api:keyword><api:keyword scheme="mesh">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Female</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="2739700" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1007214867" last-modified-when="2024-03-16T19:34:26.123+00:00"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="full">From the Department of Gender and Health, Academic Medical Center, University of Amsterdam, Amsterdam; and the</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01122527242.16</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address><api:line type="full">Institute of Medical Technology Assessment,</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01167771713.07</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address><api:line type="full">Department of Public Health and</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01114410042.37</api:identifier></api:identifiers></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JCM</api:initials><api:first-names>JCM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Erasmus University Rotterdam</api:line><api:line type="city">Rotterdam</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01173526040.47</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10947893</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>0.94</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Internal Medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Breast Cancer</api:keyword><api:keyword scheme="rcdc">Cardiovascular</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="rcdc">Aging</api:keyword><api:keyword scheme="rcdc">Prevention</api:keyword><api:keyword scheme="rcdc">Heart Disease</api:keyword><api:keyword scheme="rcdc">Heart Disease - Coronary Heart Disease</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Breast Neoplasms</api:keyword><api:keyword scheme="mesh">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Hip Fractures</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Netherlands</api:keyword><api:keyword scheme="mesh">Risk Assessment</api:keyword><api:keyword scheme="mesh">Time Factors</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Green OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.2</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk–benefit ratios in healthy Dutch women</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="242028" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000088807200007" last-modified-when="2024-03-14T05:51:12.307+00:00"><api:citation-count>6</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JCM</api:initials><api:first-names>JCM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000088807200007&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2796.2000.00714.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2796.2000.00714.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2796.2000.00714.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2796</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">345GA</api:identifier><api:identifier scheme="pubmed">10947893</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF INTERNAL MEDICINE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>breast neoplasms</api:keyword><api:keyword>coronary heart disease</api:keyword><api:keyword>hip fractures</api:keyword><api:keyword>hormone replacement therapy</api:keyword><api:keyword>middle age</api:keyword><api:keyword>models, theoretical</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record><api:record format="native" id="25294" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000088807200007" last-modified-when="2014-07-25T11:08:11.3+01:00"><api:citation-count>5</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Moerman</api:last-name><api:initials>CJ</api:initials><api:first-names>CJ</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2594" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2594"/></api:links><api:last-name>Van Hout</api:last-name><api:initials>BA</api:initials><api:first-names>BA</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bonneux</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Witteman</api:last-name><api:initials>JCM</api:initials><api:first-names>JCM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J INTERN MED</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>breast neoplasms</api:keyword><api:keyword>coronary heart disease</api:keyword><api:keyword>hip fractures</api:keyword><api:keyword>hormone replacement therapy</api:keyword><api:keyword>middle age</api:keyword><api:keyword>models, theoretical</api:keyword><api:keyword>ESTROGEN REPLACEMENT THERAPY</api:keyword><api:keyword>HEART-DISEASE</api:keyword><api:keyword>ROTTERDAM</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>143</api:begin-page><api:end-page>150</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>248</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Breast Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hip Fractures</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Time Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Breast Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hip Fractures</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Time Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Breast Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Aging</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Prevention</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Heart Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Heart Disease - Coronary Heart Disease</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Breast Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Estrogen Replacement Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hip Fractures</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Netherlands</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Risk Assessment</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Time Factors</api:keyword><api:keyword origin="record-data" source="wos-lite">breast neoplasms</api:keyword><api:keyword origin="record-data" source="wos-lite">coronary heart disease</api:keyword><api:keyword origin="record-data" source="wos-lite">hip fractures</api:keyword><api:keyword origin="record-data" source="wos-lite">hormone replacement therapy</api:keyword><api:keyword origin="record-data" source="wos-lite">middle age</api:keyword><api:keyword origin="record-data" source="wos-lite">models, theoretical</api:keyword><api:keyword origin="record-data" source="wos">breast neoplasms</api:keyword><api:keyword origin="record-data" source="wos">coronary heart disease</api:keyword><api:keyword origin="record-data" source="wos">hip fractures</api:keyword><api:keyword origin="record-data" source="wos">hormone replacement therapy</api:keyword><api:keyword origin="record-data" source="wos">middle age</api:keyword><api:keyword origin="record-data" source="wos">models, theoretical</api:keyword><api:keyword origin="record-data" source="wos">ESTROGEN REPLACEMENT THERAPY</api:keyword><api:keyword origin="record-data" source="wos">HEART-DISEASE</api:keyword><api:keyword origin="record-data" source="wos">ROTTERDAM</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Cardiovascular System &amp; Hematology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0954-6820" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974109" title="Journal of Internal Medicine"><api:records><api:record source-name="summary"><api:title>Journal of Internal Medicine</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1221/relationships"/></api:object></api:result></api:response>